Straus Farber, R., Walker, E. L., Diallo, F., Onomichi, K., Riley, C., Zhang, L., Zhu, W., De Jager, P. L., & Xia, Z. (2024). A randomized cross-over trial of prebiotics and probiotics in multiple sclerosis: Trial feasibility, supplement tolerability and symptom abatement. Multiple Sclerosis and Related Disorders, 89, 105762. https://doi.org/10.1016/j.msard.2024.105762

Leavitt, V. M., Bae, C., Shinohara, R. T., Weinstein, S. M., Schmidt, H., Aoun, S. M., Solari, A., & Solomon, A. J. (2024). Diagnosis concealment behaviors and disclosure beliefs are associated with health and quality of life in people with multiple sclerosis. Multiple Sclerosis and Related Disorders, 87, 105628. https://doi.org/10.1016/j.msard.2024.105628

Holtzer, R., Motl, R. W., Wagshul, M. E., Picone, M. A., Hernandez, M. E., Izzetoglu, M., Lipton, M. L., & Foley, F. W. (2024). Life space assessment and falls in older adults with multiple sclerosis. Multiple Sclerosis and Related Disorders, 87, 105671. https://doi.org/10.1016/j.msard.2024.105671

Leavitt, V. M., Dworkin, J. D., Kalina, T., & Ratzan, A. S. (2024). Sex differences in brain resilience of individuals with multiple sclerosis. Multiple Sclerosis and Related Disorders, 87, 105646. https://doi.org/10.1016/j.msard.2024.105646

Leavitt, V. M., Dworkin, J. D., Galioto, R., & Ratzan, A. S. (2024). Disparities in DMT treatment: Demographic and neurocognitive differences between MS patients currently treated versus not treated with disease-modifying therapies. Multiple Sclerosis and Related Disorders, 85, 105508. https://doi.org/10.1016/j.msard.2024.105508

Motl, R. W., Foley, F. W., Picone, M. A., Lipton, M. L., Izzetoglu, M., Hernandez, M. E., & Holtzer, R. (2024). Initial validation of the university of Alabama Birmingham study of aging life-space assessment in older adults with multiple sclerosis. Multiple Sclerosis and Related Disorders, 82, 105354. https://doi.org/10.1016/j.msard.2023.105354

Petracca, M., Palladino, R., Droby, A., Kurz, D., Graziano, N., Wang, K., Riley, C., Howard, J., Klineova, S., Lublin, F., & Inglese, M. (2023). Disability outcomes in early-stage African American and White people with multiple sclerosis. Multiple Sclerosis and Related Disorders, 69, 104413. https://doi.org/10.1016/j.msard.2022.104413

Buyukturkoglu, K., Dworkin, J. D., Leiva, V., Provenzano, F. A., Guevara, P., De Jager, P. L., Leavitt, V. M., & Riley, C. S. (2022). Brain volumetric correlates of remotely versus in-person administered symbol digit modalities test in multiple sclerosis. Multiple Sclerosis and Related Disorders, 68, 104247. https://doi.org/10.1016/j.msard.2022.104247

Leavitt, V. M., Kever, A. M., Weinstein, S. M., Shinohara, R. T., Schmidt, H., Aoun, S. M., Solari, A., & Solomon, A. J. (2022). Diagnosis concealment is prevalent in MS, and associated with diagnosis experience. Multiple Sclerosis and Related Disorders, 68, 104373. https://doi.org/10.1016/j.msard.2022.104373

Boorgu, D. S. S. K., Venkatesh, S., Lakhani, C. M., Walker, E., Aguerre, I. M., Riley, C., Patel, C. J., De Jager, P. L., & Xia, Z. (2022). The impact of socioeconomic status on subsequent neurological outcomes in multiple sclerosis. Multiple Sclerosis and Related Disorders, 65, 103994. https://doi.org/10.1016/j.msard.2022.103994

Kever, A., Walker, E. L. S., Riley, C. S., Heyman, R. A., Xia, Z., & Leavitt, V. M. (2022). Association of personality traits with physical function, cognition, and mood in multiple sclerosis. Multiple Sclerosis and Related Disorders, 59, 103648. https://doi.org/10.1016/j.msard.2022.103648

Epstein, S., Xia, Z., Lee, A. J., Dahl, M., Edwards, K., Levit, E., Longbrake, E. E., Perrone, C., Kavak, K., Weinstock-Guttman, B., Diallo, F., Ricci, A., Riley, C. S., De Jager, P. L., Farber, R., & Wesley, S. F. (2022). Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data. Multiple Sclerosis and Related Disorders, 57, 103433. https://doi.org/10.1016/j.msard.2021.103433

Epstein, S. E., Levin, S., Onomichi, K., Langston, C., Yeshokumar, A., Fabian, M., Sand, I. K., Klineova, S., Lublin, F., Dykstra, K., Xia, Z., De Jager, P., Levine, L., Farber, R., Riley, C., & Vargas, W. S. (2021). Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease: The difficulty of predicting relapses. Multiple Sclerosis and Related Disorders, 56, 103229. https://doi.org/10.1016/j.msard.2021.103229

Epstein, S., Fong, K. T., De Jager, P. L., Levine, L., Riley, C., Wesley, S., Vargas, W. S., & Farber, R. (2021). Evaluation of ocrelizumab in older progressive multiple sclerosis patients. Multiple Sclerosis and Related Disorders, 55, 103171. https://doi.org/10.1016/j.msard.2021.103171

Klineova, S., Harel, A., Straus Farber, R., DeAngelis, T., Zhang, Y., Hentz, R., Leung, T. M., Fong, K., Smith, T., Blanck, R., & Zhovtis-Ryerson, L. (2021). Outcomes of COVID-19 infection in multiple sclerosis and related conditions: One-year pandemic experience of the multicenter New York COVID-19 Neuroimmunology Consortium (NYCNIC). Multiple Sclerosis and Related Disorders, 55, 103153. https://doi.org/10.1016/j.msard.2021.103153

Katz Sand, I. B., Fitzgerald, K. C., Gu, Y., Brandstadter, R., Riley, C. S., Buyukturkoglu, K., Leavitt, V. M., Krieger, S., Miller, A., Lublin, F., Klineova, S., Fabian, M., & Sumowski, J. F. (2021). Dietary factors and MRI metrics in early Multiple Sclerosis. Multiple Sclerosis and Related Disorders, 53, 103031. https://doi.org/10.1016/j.msard.2021.103031